Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II

Nephrol Dial Transplant. 2005 Feb;20(2):444-6. doi: 10.1093/ndt/gfh544.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use*
  • Fondaparinux
  • Heparin / adverse effects*
  • Humans
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation
  • Male
  • Middle Aged
  • Polysaccharides / therapeutic use*
  • Thrombocytopenia / drug therapy*
  • Thrombocytopenia / etiology*
  • Thrombosis / drug therapy
  • Treatment Outcome

Substances

  • Anticoagulants
  • Polysaccharides
  • Heparin
  • Fondaparinux